Immunization, Hib3 in France
France: Immunization, Hib3 was 96.0% in 2024. ▲ Rising
Immunization, Hib3 in France, 1998–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in France is 96.0%, measured in 2024.
That represents a change of up 4.3% over ten years.
Over the whole period, immunization, hib3 in France peaked at 98.0% in 2011 and was at its lowest, 79.0%, in 1998.
France ranks 46th of 191 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 27 years of available data.
Immunization, Hib3 in France, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1998 | 79.0% | — |
| 1999 | 85.0% | +7.6% |
| 2000 | 86.0% | +1.2% |
| 2001 | 86.0% | +0.0% |
| 2002 | 87.0% | +1.2% |
| 2003 | 87.0% | +0.0% |
| 2004 | 97.0% | +11.5% |
| 2005 | 97.0% | +0.0% |
| 2006 | 97.0% | +0.0% |
| 2007 | 97.0% | +0.0% |
| 2008 | 97.0% | +0.0% |
| 2009 | 97.0% | +0.0% |
| 2010 | 97.0% | +0.0% |
| 2011 | 98.0% | +1.0% |
| 2012 | 98.0% | +0.0% |
| 2013 | 88.0% | -10.2% |
| 2014 | 92.0% | +4.5% |
| 2015 | 96.0% | +4.3% |
| 2016 | 95.0% | -1.0% |
| 2017 | 95.0% | +0.0% |
| 2018 | 95.0% | +0.0% |
| 2019 | 95.0% | +0.0% |
| 2020 | 96.0% | +1.1% |
| 2021 | 96.0% | +0.0% |
| 2022 | 96.0% | +0.0% |
| 2023 | 96.0% | +0.0% |
| 2024 | 96.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 82.0% | 79.0% | 85.0% | 2 |
| 2000s | 92.8% | 86.0% | 97.0% | 10 |
| 2010s | 94.9% | 88.0% | 98.0% | 10 |
| 2020s | 96.0% | 96.0% | 96.0% | 5 |
Countries ranked near France
More health data for France
- Un projection of annual infant deaths, annual growth rate -1.31 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0689 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,016 deaths per 1,000 people (2090)
- Number of infants who die before age 1 603 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0261 units per person (2025)
- Population ages 05-09, male, annual growth rate -1.87 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0274 units per person (2025)
- Population ages 10-14, female, annual growth rate -1.54 % change on previous year (2025)
Frequently asked questions
- What is immunization, hib3 in France?
- Immunization, hib3 in France was 96.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in France?
- The highest recorded value was 98.0% in 2011.
- What is the lowest immunization, hib3 recorded in France?
- The lowest recorded value was 79.0% in 1998.
- How does France rank for immunization, hib3?
- France ranks 46th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in France?
- Over the last ten years it is up 4.3%. The long-run trend across the full record is rising.
- Where does this France data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 27 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.